Skip to main content
ACOG logo

ACOG · Alpha Cognition Inc. · Financials

Track ACOG — free
$8.90 +0.00 (+0.00%) At close · Sep 11
Market Cap
$192.30M
Shares
21.78M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$10.22M
FY2025
Net Income
-$20.67M -39.8%
FY2025 Net Income FY2023–FY2025
Gross Margin
94.1%
FY2025
Operating Margin
-221.72%
FY2025
Diluted EPS
-$1.18 +42.2%
FY2025 Diluted EPS FY2023–FY2025
Operating Cash Flow
-$20.38M -162.8%
FY2025 Operating Cash Flow FY2023–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023
$15.26M $10.22M
$603.4K
$9.62M
94.1%
$4.17M $1.87M $3.92M $4.88M
$7.94M $5.05M
$36.2M $29.08M $8.01M
$90.39K $21.55K $79.88K
$173.03K $58.57K $81.22K $84.48K
$32.88M $12.01M $9.94M
$38.18M $32.88M $12.01M
-$26.66M -$22.66M -$12.01M -$9.94M
-221.72%
-$26.49M -$22.6M -$11.93M -$9.85M
$89.96K $105.27K $17.52K
$161.66K $6804
$5.65M $1.99M -$2.78M -$3.83M
-$21.01M -$20.67M -$14.79M -$13.76M
-202.24%
-$14.64M -$13.78M
USD/shares -$0.94 -$1.17 -$2.04 -$3.84
USD/shares -$0.97 -$1.18 -$2.04 -$3.84
shares 17.68M 7.25M 3.59M
shares 17.68M 7.25M 3.59M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 5.40×
EV/EBIT
Peer median 8.97×
P/E (TTM)
Peer median 8.07×

Peer medians compare against the 311 similar-size Biotechnology companies (of 536 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component FY2025
United States $6,792,024
China $3,428,251

By Product & Service (USD)

Component FY2025
Product Net $6,792,024
License $3,428,251
Licensing $598,430
Key facts CIK 1655923 CUSIP 02074J501 13F (30d) 19 filings 19 filers Visit website Investor relations